---
figid: PMC4268024__CTS-7-500-g003
figtitle: Effect and mechanisms of HDL‐induced platelet activation and thrombosis
organisms:
- Mus musculus
- Rattus norvegicus
- Oryctolagus cuniculus
- Sus scrofa
- Homo sapiens
- Candida dubliniensis
- bacterium 1-smooth
pmcid: PMC4268024
filename: CTS-7-500-g003.jpg
figlink: /pmc/articles/PMC4268024/figure/cts12186-fig-0003/
number: F3
caption: 'The effect and mechanisms of HDL‐induced platelet activation and thrombosis.
  HDL inhibits platelet activation by a variety of mechanisms (right). (1) HDL abolishes
  LDL or ox‐LDL‐mediated platelet activation via decreasing the expression of P‐selective
  receptor, ROS, and CD40 ligand (CD40L) signal. (2) After infusion of apoA‐I or apoA‐I
  mimetics, HDL decreases the level of thromboxane A2 (TXA2), prostacyclin H2 (PGH2),
  PGE2, and inhibits the activation of fibrinogen/GPIIa/IIIb signal pathway via SR‐B1‐dependent
  manner, which prevents the activation of platelet in hyperlipidemic mice. HDL can
  also act indirectly on platelet activation and regulating the function of endothelial
  cells (left). (1) HDL down‐regulates the release of PAF, VCAM‐1, and TXA2 via inhibition
  of the expression of acetyl‐CoA: lysoPAF acetyltransferase (lyso‐PAF) via SR‐B1
  or S1P3‐dependent signaling pathway, such as Src or PI3K. (2) HDL up‐regulates endothelial
  cell PGI2 and NO production via SR‐B1, which can decrease platelet aggregation and
  activation.'
papertitle: 'High‐Density Lipoprotein: A Novel Target for Antirestenosis Therapy.'
reftext: Kai Yin, et al. Clin Transl Sci. 2014 Dec;7(6):500-511.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9435258
figid_alias: PMC4268024__F3
figtype: Figure
organisms_ner:
- Sus scrofa
- Mus musculus
redirect_from: /figures/PMC4268024__F3
ndex: 1969bd12-df02-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4268024__CTS-7-500-g003.html
  '@type': Dataset
  description: 'The effect and mechanisms of HDL‐induced platelet activation and thrombosis.
    HDL inhibits platelet activation by a variety of mechanisms (right). (1) HDL abolishes
    LDL or ox‐LDL‐mediated platelet activation via decreasing the expression of P‐selective
    receptor, ROS, and CD40 ligand (CD40L) signal. (2) After infusion of apoA‐I or
    apoA‐I mimetics, HDL decreases the level of thromboxane A2 (TXA2), prostacyclin
    H2 (PGH2), PGE2, and inhibits the activation of fibrinogen/GPIIa/IIIb signal pathway
    via SR‐B1‐dependent manner, which prevents the activation of platelet in hyperlipidemic
    mice. HDL can also act indirectly on platelet activation and regulating the function
    of endothelial cells (left). (1) HDL down‐regulates the release of PAF, VCAM‐1,
    and TXA2 via inhibition of the expression of acetyl‐CoA: lysoPAF acetyltransferase
    (lyso‐PAF) via SR‐B1 or S1P3‐dependent signaling pathway, such as Src or PI3K.
    (2) HDL up‐regulates endothelial cell PGI2 and NO production via SR‐B1, which
    can decrease platelet aggregation and activation.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HDL
  - SRC
  - AKT1
  - CD40LG
  - NOS3
  - FGG
  - Wdtc1
  - Mdga2
  - Paf
  - Pclaf
  - Scarb1
  - Pik3r1
  - Src
  - Akt1
  - Cd40lg
  - Sryip3
  - Nos3
  - Ptgir
  - gp
  - Histamine
  - PGE2
---
